Latest Cancer vaccine Stories
According to the new report from BCC Research, the global market for cancer vaccines is expected to grow to $4.3 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.3%.
Active Immunotherapy Targets hTERT Gene Associated with 85% of Cancers PLYMOUTH MEETING, Pa., Dec. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Dr. Yang led Janssen's prostate cancer and solid tumor therapeutic area in the U.S. PLYMOUTH MEETING, Pa., Dec. 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
LOS ANGELES, Dec. 17, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
SAN DIEGO, Dec. 11, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
DALLAS, December 4, 2014 /PRNewswire/ -- ReportsnReports.com adds The Human Microbiome: Biomedical Implications and Birth of a Market 2014 research report of 94 pages to
A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate.
-- Plans to Initiate Clinical Studies of Proprietary CAR-T Cell Immunotherapy for Selected Solid Tumors -- SHANGHAI, Nov.
- Having no light.
- Of or relating to the region of a body of water that is not reached by sunlight and in which photosynthesis is unable to occur.